A review of the latest executive moves in the pharma industry over the past several months.
Tag Archive for: IO Biotech
Advances in immuno-oncology and adaptive cell therapy that began about a decade ago are enabling fresh, biology-driven approaches to bring therapeutic cancer vaccines closer to fruition.